Feeds:
Posts
Comments

Posts Tagged ‘REUTERS’

REUTERS: British scientists say they have developed a lab test that can accurately distinguish prostate cancer from healthy tissue and other prostate conditions. READ MORE>

Researchers at a genetics and diagnostics firm Oxford Gene Technology say the set of biological signals, or biomarkers, they have identified was able to distinguish healthy tissue and benign prostate disease from prostate cancer with 90 percent accuracy in initial laboratory sample tests.

A full test for use in doctors’ clinics is likely to be at least five years off, they said, but their pilot study testing around 130 samples showed encouraging results in a disease area where more accurate diagnostic tests are sorely needed.

Read Full Post »

REUTERS: Men who show signs that their disease has returned after prostate cancer treatment are still more likely to die of other causes, a new study in US veterans shows. READ MORE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: A detailed analysis of the findings of a Swedish study into the effectiveness of prostate cancer screening using PSA tests is provided here by Mike Scott: READ MORE>

The data from the Göteborg study may still not provide a convincing rationale for mass, population-based screening based on use of the PSA test, but it certainly does set the standard for what must be expected from any new test that may come along and show promise as a true screening test for prostate cancer in the future.

Earlier stories

Reuters and other news agencies gave widespread coverage to the Swedish study over recent days.

REUTERS: An extensive study of 20,000 men into the merits of screening men between the ages of 50 and 65 for prostate cancer has found it can cut death rates from the disease by as much as half, report Swedish scientists. READ MORE> and HERE> and HERE> and HERE> and HERE>

Over 14 years of follow-up, prostate cancer death rates were cut almost by half in the (PSA) screening group compared with the non-screening group, as men were diagnosed and treated in time to stop the cancer from killing them.

Jonas Hugosson, who led the study, said the results showed that PSA screening of all men this age group “can result in a relevant reduction in cancer mortality.”

But the findings don’t necessarily mean nationwide prostate screening programs should introduced, experts said, since they run the risk of significant overdiagnosis of tumors in men who would not have suffered any harm from their cancer.

Read Full Post »

REUTERS: Even without treatment, only a small minority of men diagnosed with early-stage prostate cancer die from the disease, Swedish researchers report. READ MORE>

Read Full Post »

REUTERS: The US Food and Drug Administration has approved the sale of Amgen Inc’s osteoporosis drug Prolia – denosumab – to help prevent fractures in advanced cancer patients just days after the medicine received European approval. It will cost $US825 per 60 milligram injection. READ MORE>

Read Full Post »

REUTERS: Hypo-fractionated radiation treatment – a newer type of radiation treatment that delivers higher doses of radiation in fewer treatments than conventional radiation therapy – is significantly more effective in stopping prostate cancer from growing in high risk patients. READ MORE>

Read Full Post »

REUTERS:  Surgeons are increasingly turning to high-tech robotic equipment to operate on patients with prostate cancer and other conditions, but some medical authorities worry about inadequate training and lax standards among practitioners. READ MORE>

Read Full Post »

REUTERS: Dendreon Corp says it expects quick success for its Provenge prostate cancer treatment if it is approved by US regulators, with initial demand for the world’s first cancer vaccine exceeding supply. READ MORE>

Read Full Post »

JUNE 25: REUTERS: OncoGenex Pharmaceuticals Inc says it has reached an agreement with US health regulators to amend the design of a late-stage trial of its lead prostate cancer drug, OGX-011. READ MORE>

Read Full Post »

Follow

Get every new post delivered to your Inbox.

Join 26 other followers